Zoetis has announced the launch of Ketavet.
The intravenous anaesthetic solution containing ketamine is available in 10ml and 50ml presentations. The new product coincides with the re-classification of ketamine as a schedule 2 drug.
Ketavet is a clear, colourless solution for injection containing ketamine 100 mg/ml (equivalent to 115.36 mg/ml ketamine hydrochloride) with benzethonium chloride 0.1 mg/ml as a preservative. It can be used to induce anaesthesia in horses in conjunction with xylazine, detomidine or romifidine.
Ketavet, along with other ketamine containing products, has been moved to Schedule 2 of the Misuse of Drugs Regulations, which took effect from 30 November 2015. This enables tighter controls on the record keeping, prescribing and safe custody of products containing this active. More information on the specific requirements which will need to be met following the schedule change can be found on the VMD website https://www.gov.uk/government/news/amendments-to-the-misuse-of-drugs-regulations-2001
Penny McCann, Equine Product Manager at Zoetis said: "Ketavet is an important product in our anaesthesia portfolio. We are keen to help veterinary surgeons keep up-to-date with the reclassification of ketamine and with this in mind our new product packaging clearly reflects ketamine’s revised status as a schedule 2 drug."
For more information, contact your Zoetis Account Manager.
A Jack Russell from Thurso had a bit of a surprise last week, when it looked down the stethoscope to find Prince Charles at the other end.
The slightly unlikely encounter happened when the prince visited the newly-extended North Highland College Rural Studies Centre.
The purpose-built centre, which houses veterinary nursing, gamekeeping and equestrian students, boasts a nurse training area complete with theatre, prep room, isolation area and consultation room, where Prince Charles was invited to watch a bandaging demonstration and listen to the dog's heart murmur.
Over seventy guests attended the event and were introduced to Prince Charles before he was presented with a gift from vet nursing student Paula Morgan. Paula from Ayrshire, who is a former veterinary nursing student of the College said: "The facility is an absolutely fantastic asset to the College. It is so good for students having the equestrian studies section based just across the courtyard here too! It was a great honour to present Prince Charles with his gift at his visit to the newly revamped centre."
Alternative picture caption, anyone?
Speed Reader can test for T4, Cortisol, CPSE, Progesterone and cCRP. Virbac highlights that it is the only in-clinic diagnostic biomarker test for CPSE, to screen dogs for Benign Prostatic Hyperplasia, of which 80% of intact male dogs over the age of 5 years old are at risk of developing (1,2).
Virbac says the Speed Reader gives practices an opportunity to increase in-clinic diagnostic testing, reduce their reliance on external laboratories, deliver immediate results and improve profitability.
Offered with an intuitive touch screen user interface and integrated printer, Speed Reader tests can be performed in as little as 15 minutes using a simple step-by-step procedure displayed on the touch screen.
Andrew Connolly, Head of Marketing – Companion Animals at Virbac said: "The Speed Reader biomarker range is a fantastic addition to Virbac’s diagnostic portfolio.
"Not only does Speed Reader offer practices improved in-clinic diagnostic testing, but having listened to customer feedback we are also offering Speed Reader with transparent, straightforward pricing and without complex commitment contracts."
For more information, speak to your Virbac Territory Manager.
References
Genitrix has launched Libromide, the first licensed formulation of potassium bromide for the treatment of canine epilepsy, following what the company believes to be the largest ever trial of dogs suffering from epilepsy.
Genitrix says the availability, for the first time, of a licensed formulation of potassium bromide should give veterinary surgeons and pet owners the reassurance that the rigorous authorisation process provides. It ensures, for instance, that the product has been developed especially for dogs and that it is manufactured in accordance with EU regulations. It also ensures that the product has been extensively and independently trialled, proven to be efficacious without adverse reactions, and that the necessary pharmacovigilance is in place to support it.
The company also says that the availability of a licensed product paves the way for more comprehensive information to be provided to veterinary surgeons on the use of potassium bromide in treating seizures. The Veterinary Medicines Directorate (VMD) imposes restrictions on educational materials supplied by manufacturers of unlicensed products, an approach which has created a 'knowledge gap' among many veterinary surgeons in general practice, according to some canine epilepsy experts.
Libromide tablets are intended for use in epileptic dogs which have already commenced therapy with Phenobarbital. Phenobarbital acts to increase the effects of the GABA inhibitory neurotransmitter in the central nervous system. Potassium bromide is synergistic with Phenobarbital and raises the seizure threshold level in epileptic dogs.
Libromide is classified as POM-V and will be available in 325 mg tablets in packs of 100 and 500 tablets.
Rodolfo Cappello DVM PhD DipECVN MRCVS, RCVS and European Specialist in Neurology and Neurosurgery, Head of Neurology Services at North Downs Specialist Referrals, Surrey, said: "I've been successfully using potassium bromide for the treatment of epilepsy in dogs for over 15 years. The main problem has been that it's not been licensed as a medicine. With the launch of Libromide, potassium bromide finally achieves the status of an approved pharmaceutical. We will now be able to monitor quality, efficacy and side effects which will enable us to offer a more professional approach to the treatment of seizures."
Howard Wilder, founder and managing director of Genitrix, added: "Canine epilepsy is an all too common disease with estimates suggesting it affects four in every hundred dogs in the UK. It's also an illness which is not well enough understood with the lack of up to date information available to veterinary surgeons being a contributing factor.
We felt there was an opportunity to bring a licensed product to market and have invested hundreds of thousands of pounds in the process of development and trialling Libromide. We're delighted to make it available to veterinary professionals and hope its launch will be the first step in improving treatment approaches for this distressing disease."
The RCVS Disciplinary Committee heard two charges against Dr Nemes, the first being that he had posted comments on social media about another veterinary surgeon, his employer, Dr Toth, which were offensive and/or derogatory and/or inappropriate.
The second charge was that Dr Nemes had posted his comments without having sufficient regard to maintaining their confidentiality and/or privacy.
Dr Nemes admitted the charges, though he did inform the Committee that his admission with respect to the second charge was caveated by the proposition that the comments were posted in private messages on Facebook with a limited membership, namely employees of Healers Veterinary Centre (Dr Toth’s practice).
The Committee noted the Respondent’s admissions as to the charges raised against him and pronounced the facts found proved.
In relation to the first charge, the Committee found that the comments on social media were, without a doubt, highly unprofessional. They included offensive language, were gratuitously personal against Dr Toth, and were made within an online chat which included junior lay staff, all employed by Dr Toth.
This behaviour was seen to directly contravene a numbers of parts of the RCVS Code of Professional Conduct, in particular Paragraph 5.3 that states: "Veterinary Surgeons and Veterinary Nurses should not speak or write disparagingly about another Veterinary Surgeon or Veterinary Nurse."
In relation to the second charge, the Committee found that Dr Nemes had paid no regard to maintaining the confidentiality and/or privacy of his malicious and damaging entries to the chat.
At the outset of his evidence, Dr Nemes admitted that the proven charges amounted to serious professional misconduct. The Committee noted however that the question of whether he was guilty of serious professional misconduct or not was in fact a matter for it to decide, notwithstanding his admission.
The Committee considered the fact that the period of time that Dr Nemes was involved in making postings was effectively about two weeks, that his involvement followed his wife’s dismissal from employment (representing a breach of Dr Nemes’ resignation conditions), and that he was very stressed at the time.
It also considered Dr Nemes’ point that he had never anticipated that Dr Toth would see the Facebook Messenger conversation, and that the relevant RCVS supporting guidance to the Code concerning good practice when using social media and online networking forums was only published in late November 2014 when Dr Nemes’ involvement in the conversation was virtually at an end.
In summing up, Ian Green, Chair of the Committee, said: "The Committee carefully considered the circumstances surrounding the Facebook Messenger entries which the Respondent posted from 13 November 2014. It noted that at the time he had handed in his resignation, morale at the practice was very low. The Facebook Messenger chat site had been started amongst the receptionist/animal carers. A perusal of the entries before the Respondent joined on 13 November 2014 demonstrates that morale was low among that group.
"…Notwithstanding the nature of the remarks posted on the Facebook Messenger, which the Committee deplores, it has reached the conclusion that, whilst the Respondent’s behaviour amounts to misconduct and falls short of the standards expected of a member of the veterinary profession, it does not amount to serious misconduct and does not fall far short.
"In the circumstances it has reached the unusual conclusion that, notwithstanding the Respondent’s admission, the appropriate finding is that he is not guilty of disgraceful conduct in a professional respect."
VetSurgeon members, husband and wife Cat Henstridge and Dave Hough MsRCVS have set up vCPD, a low cost CPD company based in the West Midlands.
Cat said: "Many of you will have noticed how CPD has become extremely expensive with some of the larger providers. Single days of theory based lectures are often well over £300+VAT, even for vet nurses, and more practical sessions can be far more than this. In these tough economic times it is a cost many practices can ill afford but one which, due to the RCVS regulations on Continuing Professional Development for both Vets and Vet Nurses, they are often forced to meet.
"vCPD is very different. Courses cost only £150 +VAT , all of which are given by highly qualified and experienced professionals (often the very same ones used by the more expensive companies) at an extremely convenient location, with excellent transport links and plenty of free parking, in the West Midlands. We are initially concentrating on vet nurses but will be expanding to vets later in the year."
You can find out more, view the courses and download a booking form by visiting http://www.vcpd.co.uk/. You can also follow vCPD on facebook and twitter.
Dermanolon contains triamcinolone acetonide and salicylic acid. Presented in a 75ml spray bottle, Dechra says it is designed to target lesions in hard to access spots and is a useful alternative for animals when shampooing is not possible.
Triamcinolone acetonide, a moderately potent steroid with an anti-inflammatory and vasoconstrictive action, suppresses the inflammatory response and the symptoms of various disorders often associated with itching.
Salicylic acid gives a keratolytic effect and also removes excess skin cells when applied cutaneously and provides a drying effect, which prevents maceration.
Dechra Brand Manager Carol Morgan said: "Seborrhoeic dermatitis is associated with a higher skin pH compared to that of healthy dogs so Dermanolon’s low pH of approximately 2.7 reduces the pH of the skin following application giving an antibacterial and antimycotic effect.
"It also contains ethanol that prevents the build-up of a greasy film on the skin and has bactericidal properties."
Carol added: "Seborrhoeic dermatitis can be a debilitating condition for animals and a challenge to treat effectively. Adding Dermanolon to our portfolio offers veterinary professionals another valuable tool for the care and treatment of animals with dermatological diseases."
For more information on Dechra’s dermatology range, visit: www.dechra.co.uk.
Ziapam is licensed for the short-term control of convulsive disorders and muscle spasms of central and peripheral origin, and for use as part of a sedation or pre-anaesthetic protocol. It is presented in packs containing 6 x 2ml vials.
Simon Boulton MRCVS, marketing manager at TVM said: "As a scheduled intravenous drug it is important that we have batch traceability and the proper monitoring of any side effects of such drugs to make sure current guidelines for use in the SPC are correct. Ziapam is kept at the same concentration of the previously used human generics on the cascade for ease of transition."
Simon added: "Furthermore, we’ve purposefully priced Ziapam such that it is only costs a few pence per dose more than the human generic."
TVM UK has also produced a dosing guide for practices which illustrates the different indications and associated treatment guidelines.
For a copy of the dosing guide or for more information, contact your local Territory Manager, email: help@tvm-uk.com, or call: 01737 781 416.
In part one of the article, Professor Ernst made the case that homeopathy has no place in veterinary (or human) evidence-based medicine.
In part two, he considered a number of other types of so-called alternative medicine (or 'SCAM', as he called it in the self-published version) for animals, including acupuncture, chiropractic, energy healing and dietary supplements, concluding that most such SCAMS are unproven and that 'arguably it is unethical to use unproven medicines in routine veterinary care'.
Now is it just me, or does anyone else find the Veterinary Record position rather worrying?
Surely a scientific journal should concern itself with one thing and one thing only: the search for scientific truth?
Surely, therefore, the question of how many veterinary surgeons use a therapy is completely irrelevant. Or am I being idealistic?
I also struggle with the idea that Professor Ernst could be told to go away and provide more balance.
How exactly is anyone supposed to balance the argument that there's no evidence that a therapy works? The only counter or balancing argument would be that it does. Catch 22.
Most learned people know that homeopathy is not just a little bit implausible, but completely off-the-scale-bonkers-in-a-'world-is-not-flat-sort-of-a-way', along with energy healing and chiropractic.
But acupuncture? I'll bet Professor Ernst's words will make for uncomfortable reading for some. That's precisely what seems to have made the Veterinary Record balk. But surely that's the whole point of science. To challenge our beliefs, even (or especially) if it makes us uncomfortable.
You can read Professor Ernst's blog at: https://edzardernst.com/
Macie was rushed to the PDSA's emergency out-of-hours service after swallowing an eight-inch kitchen knife (click to enlarge image right).
Owner Irene Paisley took the puppy to the PDSA after it began choking. She said: "Macie was making a squeaking sound – I thought she’d swallowed part of a toy. Then she was sick, but there was no sign of a toy and she started choking."
Having lost her previous Staffie to cancer just two months earlier, Irene feared the worst.
"I was terrified. Poor Macie was still choking and, by the time we arrived at the vet’s, there was blood coming out of her nose. The loss of our previous dog was still very raw and the thought of losing Macie, who had only been with us for two weeks, was devastating."
The young puppy was admitted, and x-rays immediately revealed the severity of the situation. The knife handle had passed through Macie’s stomach and into her intestines, while the tip of the knife was still in her gullet. She underwent emergency surgery straight away.
Irene said: "I couldn’t believe it when they said Macie had swallowed a knife. I have no idea where she got hold of it – she could have pinched it out of the dishwasher, but no-one saw what happened. None of us could sleep that night as we knew Macie might not survive."
Happily, the operation was a success and the following morning Macie was transferred to the PDSA Pet Hospital in Shamrock Street, where her recovery began.
PDSA vet, Emily Ronald, said: "I’ve never seen an x-ray like Macie’s. She was extremely lucky to survive. Her saving grace was that she swallowed the handle-end first – the blade-end would undoubtedly have pierced her organs, likely causing fatal injuries.
"The morning after surgery, she was bouncing all over the place as if nothing had happened. Macie has been back for frequent check-ups over the past two weeks and we’re pleased she’s recovering and healing well."
Expressing her gratitude to PDSA, Irene said: “Although she’s only young, Macie is already a big part of the family. She brings us so much joy and happiness, and means the world to the children. Without PDSA, she wouldn’t have received her life-saving treatment and wouldn’t be here today.”
Emily added: "Macie is just one of the lucky pets to benefit from PDSA’s emergency service which has received generous funding from players of People’s Postcode Lottery. Thanks to their support we’re able to provide thousands of life-saving treatments across the UK."
Boehringer Ingelheim Vetmedica has launched Buscopan 20mg/ml injection, an antispasmodic treatment for use in cases of equine colic, and an aid to the symptomatic treatment of calf scour.
A sister product to Buscopan Compositum which contains both an antispasmodic and a non-steroidal component, Buscopan 20 contains only the antispasmodic component - hyoscine butylbromide.
Craig Beck, equine sales and marketing manager at Boehringer Ingelheim Vetmedica said: "Our customers have been telling us for some time that they would really welcome a Buscopan formulation without an NSAID for use in horses and cattle. I'm pleased to say that it's finally here and I'm sure that Buscopan 20 will be a very welcome addition to the armoury of both equine and cattle practitioners."
Buscopan 20 is supplied in a 50ml multi-dose bottle, and is available in veterinary wholesalers now.
For further information, please call 01344 746959.
Deltanil, which contains deltamethrin for control of external parasites in dairy cattle and sheep including lice and flies, is now available in an additional 2.5ltr HDPE plastic bottle presentation. Virbac says the new 5 year shelf life significantly facilitates effective stock management.
Neoprinil, a nil milk withhold pour-on containing eprinomectin for control of external and internal parasites in cattle, now comes in 1ltr, 2.5ltr and 5ltr bottles.
Both products are still available in the Farmpack/Flexibag presentations, which Virbac says gives suppliers, retailers and farmers a range of application options to cover all on-farm situations.
Dr. Rosie Reyneke, Technical Product Manager - Farm Animal, Virbac UK, said: "The range now caters for farms of any size across the entire breadth of sheep, beef and dairy communities and provides farmers with the options to make a choice that suits them.
"We are also delighted to be able to help simplify stock management with the additional shelf life now in place for Deltanil"
For more information, ring: 01359 243243, email: enquiries@virbac.co.uk or visit: https://uk.virbac.com.
In the week that Prince Charles has become embroiled in another row about the use of homeopathy in the NHS, British veterinary surgeons have denounced its use for the treatment of pets and other animals.
In a survey of veterinary surgeons carried out on this website, in which 460 members took part and the preliminary results of which are announced today, an overwhelming 83% said that there are no medical conditions for which homeopathy could be an effective treatment in animals. This figure included the 6.3% of participants who practice veterinary homeopathy themselves, without whom the figure would be even higher.
More specifically, when asked how they would best describe veterinary homeopathy, 4.5% said 'A reliably effective form of veterinary medicine', 8.7% said 'an occasionally effective form of veterinary medicine, 9.5% said: 'a rarely effective form of veterinary medicine, and 77.3% said: 'An ineffective form of veterinary medicine'.
The survey was carried with Alex Gough MA VetMB CertSAM CertVC PGCert MRCVS, Head of Medicine Referrals at Bath Veterinary Group.
So strongly did veterinary surgeons feel about the matter, 78.4% felt that their colleagues should not be allowed to practice homeopathy under their professional title of MRCVS. 73% said that whilst they are still allowed to do so, pet owners should be asked to sign a disclaimer that they understand that in trials, homeopathy has been shown to be ineffective.
However despite the almost universal denunciation of veterinary homeopathy within the profession, when it comes to directing their clients, it seems that many veterinary surgeons do not have quite the same courage of their convictions. Asked what would be the most appropriate response when asked by a client to refer an animal for homeopathic treatment, only 24% of vets said they would explain that homeopathy does not work and recommend the client does not self-refer for homeopathic treatment. 17.5% said they would explain that homeopathy does not work and advise the client to self-refer. 34% said that they would explain that homeopathy doesn't work and refer anyway, and 24% said they would just refer the case.
Josep Aisa has arrived from Glasgow University, where he spent four years as a lecturer focusing on soft tissue procedures. He has authored numerous scientific papers and given presentations to international veterinary meetings, specifically on orthopaedic conditions.
Josep has a keen interest in oncological surgery and also boasts a broad area of expertise including orthopaedics.
Veronica Mortera has just finished a three-year residency in Neurology and Neurosurgery at Bristol University where she specialised in spinal surgery and inflammatory diseases of the brain. In 2014, she completed an internship in Small Animal Medicine and Surgery at Glasgow University where she authored a paper on MRI abnormalities in dogs with portosystemic shunts.
Veronica also spent three months in Geneva with the World Health Organization helping in the development of Public Health guidelines.
Joining Veronica in the neurology department is Francesca de Strobel, who earned a PhD from the University of Padua, in Italy, after writing a thesis on intervertebral disc degeneration in a large animal model.
Francesca began work as a Small Animal Veterinarian and Clinical Assistant in Neurology at the University’s Veterinary Teaching Hospital before moving to the UK in 2014 to begin an internship in neurology at Dick White Referrals, where she completed a three-year residency programme in small animal veterinary neurology and neurosurgery.
She enjoys all aspects of neurology and neurosurgery, with a particular interest for spinal surgery, metabolic and intracranial disorders.
North Downs is also extending its facilities with new consultation rooms, extra theatre and procedure rooms, more kennels, new staff facilities and extended vet space, along with a new meeting room. It is also creating a central imaging suite, with new MRI and CT scanners.
Hospital director Terry Emmerson said: "These are very exciting times at NDSR as work on the new extension begins and the plans actually start to take shape.
"It’s definitely a powerful illustration of our commitment to offer the very best service possible to all our patients, both in terms of facilities and equipment and in our clinical care."
Photo: From left, Veronica Mortera, Josep Aisa and Francesca de Strobel
Dexafast is an injectable corticosteroid with potent, medium-acting, anti-inflammatory activity, indicated for the treatment of a range of inflammatory and allergic conditions in both small and large animal clinical practice.
Dr John Henderson, Large Animal Product Manager at Forte Healthcare Ltd said: "Dexafast 2mg/ml is an excellent addition to our range. This formulation of dexamethasone is used across many species on a daily basis, and Dexafast 2mg/ml gives vets a high-quality presentation of a staple medicine."
Dexafast is available in a 50ml bottle.
For further information, contact your local Forte Territory Manager, visit: https://www.fortehealthcare.ie/product/dexafast-uk-only, or email: enquiries@fortehealthcare.com.
The introduction of the compulsory microchipping law in April 2016 has meant that puppies have to be microchipped by 8 weeks of age and the breeder has to be recorded as the first keeper. This has, up to now, incurred further and often unexpected costs for new puppy owners or breeders who have had to pay an additional fee for the transfer of keepership.
From 1st February practices using BackHome microchips will register their newly implanted microchips with the UK based reunification database, PETtrac, and the online transfer of keepership from breeders to new owners will be free. A postal transfer will cost 50p.
BackHome Product Manager Madeline Haynes said: "We have listened to feedback from the veterinary profession who have stressed the importance of not only providing a fast and reliable service from a pet reunification database, but also the need for free transfer of keepership from a breeder to a new owner.
"We are delighted to have been able to facilitate this through the move to PETtrac."
PETtrac is a UK based, DEFRA compliant reunification database that offers 24/7 customer service, 365 days of the year.
The move to PETtrac will not affect pets already registered with BackHome Microchips, whose lifelong registration with previous database supplier PetLog remains unchanged.
For more information, visit: www.virbac.co.uk
*Postal transfer of keepership from breeder to new owner will cost 0.50p
Danny Chambers MRCVS had a disappointing night after seeing the Liberal Democrat share of the vote in North Cornwall decrease by 5.8%, leaving him trailing 14,752 votes behind the Conservative candidate Scott Mann who scored 30,671.
Meanwhile Ian Fleming MRCVS, who stood as an independent candidate for the Halesowen and Rowley Regis constituency, got 190 votes. The winning Conservative candidate, James Morris, gained 25,607 votes.
Many people will no doubt feel that the overall Conservative majority of 80 seats is a disastrous result; people who simply cannot bear Boris and fear what he'll do with a majority; people who saw a land of milk and honey and free broadband and publicly-owned railways that run on time and an A&E waiting time of less than 30 seconds and guillotines for the rich, only to have their hopes dashed. They must be gutted.
Equally it can be argued that this is the best possible result for the country. A decisive vote. Now, finally, we can all move on from 3 years of interminable debate about whether we're staying or going or having another referendum or cancelling the whole thing and going down the pub instead. Now the government can concentrate on implementing brexit. Perhaps the country can at last unite around that purpose.
Boris may not prove the disaster that some people think. He's not hard right. Quite the reverse. And having won all those safe Labour seats, he'll have to deliver for them. He has a good sense of humour ("Let's get breakfast done."), but that does not make him a fool or a charlatan. On the contrary, wit requires brainpower. And as for the accusations of being a liar, perhaps people will come to understand that flowery use of language does not itself make someone dishonest. Perhaps people will learn to stop interpreting his words so literally.
Time will tell, but there is cause for optimism this morning. Whichever side of the fence you sit, we must all be glad of one thing ... no more arguing about whether or not we're leaving.
Kate Murphy and Mellora Sharman from VetCT, Mayank Seth and Rachel Miller from Stansted Veterinary Specialists and Andy Kent from Blaise Referrals have all signed up to get the new VetSurgeon.org email digest of questions posted on the site and will help when they can.
To get things started, any VetSurgeon.org member who posts a question about small animal medicine AND subscribes to the daily or weekly email digest (by logging in and clicking the red box on the homepage) before close of play on 15th August 2023 will go in the hat to win a bottle of Moet champagne.
VetSurgeon.org editor Arlo Guthrie said: "There are many reasons why this new Q&A community is better for professional clinical discussions than other forms of social media, but perhaps the most important is that when you ask a question, you’re not just helping yourself.
"Your question and any answers you receive go into an easily searchable knowledgebase of experience and opinion for the benefit of everyone in the veterinary profession.
"Beyond that, we don't use an algorithm to prioritise posts you are likely to react to, so we avoid the sort of echo chamber bias found on Facebook.
"Other social media also gives undeserved equivalence to all opinions, whereas we highlight those expressed by people with advanced qualifications and experience.
"Finally, VetSurgeon.org is now about one thing and one thing only, which is vets helping each other.
"That makes us much more focused.
"All in all, it means that VetSurgeon.org is where you'll get an authoritative answer."
General practitioners are also strongly encouraged to login and subscribe to the VetSurgeon.org Digest of questions, either daily or weekly.
Arlo added: "You'll get a daily or weekly list of veterinary questions asked by your peers.
"Some you'll want to know the answer to too.
"Some you may be able to help with.
"Answers are welcome not just from Specialists and referral practitioners, but also from general practitioners, industry members and academics."
Fynadyne had been removed from sale last year after the Veterinary Medicines Directorate suspended the sale of any medicinal products containing the excipient diethanolamine (DEA), following advice to the European Medicines Agency that it could pose a risk to human health.
Finadyne 50mg/ml Solution for Injection is indicated for the alleviation of acute inflammation and pain in both cattle and pigs. It is also indicated for the alleviation of inflammation and pain associated with musculo-skeletal disorders and colic in horses.
The reformulated product has a shelf life of three years and is now available from wholesalers in 50ml and 100ml vials.
For further information, contact your MSD Animal Health account manager.
Neil, a Senior Lecturer at the University of Edinburgh Royal Dick School of Veterinary Studies, is an equine veterinary surgeon who has worked in large and small animal practice in the UK and Australia. Neil is clearly multi-talented: on top of his many and various career achievements, he was in the Cambridge Footlights and has performed in four Edinburgh Fringe Festival shows. He also plays the piano.
Danny is another multi-talented veterinary surgeon, currently working as an equine locum and well-known in the profession as an RCVS Council Member, the founder of Veterinary Voices and a campaigner against irrational forms of veterinary medicine such as homeopathy.
Ian Fleming is a Senior Vet at the PDSA, standing as an independent candidate for the Halesowen and Rowley Regis constituency.
If I was a betting man, my money would have to be on Neil: Penrith and the Border has been held by the Conservatives since 1950, most recently by Rory Stewart. Danny, on the other hand, needs to overturn a 7200 Conservative majority in his constituency, something which the latest polls suggest is a bit of an outside bet. Still, stranger things have happened.
Fort Dodge Animal Health has launched PropoClear, a short-acting, intravenous general anaesthetic for dogs and cats.
The company believes that PropoClear, based on novel lipid-free micro-emulsion technology, will deliver significant clinical benefits over conventional lipid-based propofol emulsions, and will also deliver increased cost-effectiveness and convenience to practices.
PropoClear is indicated for use as a short-acting general anaesthetic for procedures lasting up to five minutes. It is also indicated for the induction and maintenance of general anaesthesia using incremental doses and for the induction of anaesthesia where maintenance is provided by inhalation.
According to Fort Dodge, PropoClear's unique lipid-free, nano-emulsion formulation and its inclusion of antimicrobial preservatives provide the following key benefits to practices:
Dr Jo Murrell, Department of Clinical Veterinary Science, Division of Companion Animals, the University of Bristol, said: "With currently available lipid-based propofol formulations unused drug should be discarded immediately once the vial has been opened leading to drug wastage or the potential for bacterial contamination of the remaining solution if this regulation is ignored. The new lipid-free propofol formulation, which also contains antimicrobial preservatives, overcomes this limitation and will provide significant clinical benefits in terms of the 28 day shelf life once broached."
Matthew Rowe, Marketing Manager for Companion Animals at Fort Dodge, said: "In developing PropoClear, it was our goal to deliver an anaesthetic product with the same proven efficacy as the existing solution but which offered significant benefits in terms of enhanced safety, cost and convenience.
"PropoClear contains the same concentration of the established active molecule and follows familiar guide dose protocols to ensure ease of use. We have been encouraged by the positive feedback received during product trials and believe the significant advantages its offers, both clinically and financially, to practices in challenging times, will ensure its rapid adoption by veterinary practices across the UK."
The RCVS Disciplinary Committee has severely reprimanded and warned as to his future conduct a veterinary surgeon who failed to make sufficient enquiries about the location or condition of a cat; unreasonably refused to provide it with first aid and pain relief; and failed to provide it with adequate 24-hour emergency care.
Following a three-day hearing, the Committee found Marcus Kutschera, of South London Emergency Veterinary Centre, Streatham, guilty of serious professional misconduct in relation to events on 16 May 2011. Mr Kutschera was Clinical Director of the practice, which provided out-of-hours emergency services to several London veterinary practices. At about 1.45am, the practice received two telephone calls from a representative of a registered charity about a cat, which the caller considered should be seen by a veterinary surgeon as soon as possible. The charity was itself a client of one of the practices whose out-of-hours emergency services were provided by the South London Emergency Veterinary Centre. The cat was later euthanased by the RSPCA.
After listening to a recording of a telephone call between a representative of the charity and Mr Kutschera, during which Mr Kutschera failed to ask about either the condition or location of the cat, the Committee was in no doubt that the caller believed Mr Kutschera would not see the cat unless he was able to pay when it was presented. The Committee said that, once the telephone call had been received, the primary responsibility of the veterinary surgeon was the welfare of the animal, and Mr Kutschera had no good reason not to see the cat or to follow the procedures set out in the Guide to Professional Conduct 2010. If he had made proper inquiries, he would have been able to make a provisional diagnosis that the cat was likely to be euthanased. Mr Kutschera was guilty of unreasonably refusing to provide first aid and/or pain relief to the animal, and of failing to provide adequate 24-hour emergency care.
The Committee concluded that Mr Kutschera's conduct fell far short of that to be expected of a veterinary surgeon. Although he did recommend that the cat should be taken to the RSPCA, his primary concern was the ability of the client to make a payment on presentation of the cat, and not the animal's welfare. He had a responsibility for ensuring that proper emergency cover was provided.
In mitigation, the Committee noted that the event was a single, short telephone call between Mr Kutschera and the client in the early hours of the morning, and there was no evidence to suggest similar behaviour on his part on other occasions. Mr Kutschera accepted that he made no inquiries into the cat's condition or location, and the Committee accepted that he had shown some insight into what went badly wrong. He said that he had subsequently changed his practice when speaking to clients on the telephone. The Committee also took account of the impact on Mr Kutschera of the case hanging over him since the complaint was made in August 2011 and, as the cost of the Disciplinary Committee inquiry was not covered by his professional indemnity insurance, he had taken on a substantial financial commitment to pay for legal representation.
Professor Peter Lees, chairing and speaking on behalf of the Committee said: "The primary purpose of the sanction is not to punish but to protect the welfare of animals, maintain public confidence in the profession and uphold proper standards of conduct. Whilst there are undoubted financial issues that can arise in the operation of an out-of-hours service, the primary responsibility of the veterinary surgeon is for the welfare of the animal."
The Committee recommended that Mr Kutschera undertake, within 12 months, continuing professional development training, with a particular emphasis on animal welfare, ethics and client care, in the context of providing out-of-hours services. It imposed on Mr Kutschera the sanction of a severe reprimand and a warning as to his future conduct.
The annual survey gives an overview of remuneration levels within the veterinary sector.
It covers everything from basic earnings, bonuses, dividends and overtime, to benefits such as accommodation, car allowances and pensions.
SPVS is asking everyone in the veterinary profession to take part, whether they're in a clinical or non-clinical role, a vet, a nurse, a practice manager, support staff or working in industry.
The main findings of the survey will be published in a report and freely available to any participant who gives their email address at the end of the survey.
SPVS members will be able to access the full results with additional commentary and analysis.
All survey data is treated as strictly anonymous and totally confidential.
https://www.smartsurvey.co.uk/s/LOZS6O
Any questions: office@spvs.org.uk
TVM says Emedog provides less wastage, provides easier dosing and is a solution designed specifically for veterinary use.
Simon Boulton MRCVS, Marketing Manager at TVM said: "The use of apomorphine in practice is a vital first-line response when emesis is required due to the ingestion of unwanted substances.
However, 86% of vets questioned thought that wastage was an issue with Apometic and many thought that dosing was difficult in very small animals due to tiny volumes. The new solution is Emedog. Practitioners must be aware that the dose of Emedog is different to that of Apometic and use accordingly."
TVM have provided a dosing guide as part of a changeover pack to aid in the transition. For a copy, contact your local TVM territory manager, email them via help@tvm-uk.com, download from www.tvm-uk.com or ring 01737 781416.
The new structure means that all 99 members of Pennard Vets' team, who work across six sites in Kent, are now practice owners and shareholders in the business. This, says the practice, will protect it's independence and 125-year-old core values.
The group celebrated the completion of the employee ownership trust earlier this month at a summer family BBQ and party held at Hadlow Manor Hotel in Tonbridge.
Pennard Vets’ three previous sole directors, comprising of Matthew Flann, Caroline Collins and Andy Green, all worked as vets at the practice for several years before becoming part of the leadership team in 2007, and the trio will all continue to work in the business following the EOT transfer.
Andy said: “Pennard Vets is a special practice that has been a part of the fabric of the local community for 125 years and we want to be here in another 125 years. At a time when many other practices are being taken over by large corporate organisations, we knew that the EOT was the right way to guarantee an independent future for our 99 team members. Although we received plenty of interest and offers from the corporates, it was important to remain true to ourselves and our values.
“It is increasingly difficult for vets to buy into independent practices and the traditional partner progression model no longer works, so after exploring various possibilities, it became clear that the EOT option was ideal for us and protects everything that we stand for.
“Crucially, it also means Pennard Vets won’t be taken over and gives everyone in our team both autonomy and a voice, as well as safeguarding our fundamental core values that are built around compassion, client focus and continually improving everything we do. There’s no doubt this will further enhance the high standard of care that our clients enjoy and is also helping us to grow our team and attract new talent.
“As we expand our practice across Kent, we’re recruiting both vets and nurses. Every new team member becomes an employee owner and can influence the decisions we make for the future of our practice. Our people are helping to shape our employee benefits scheme and influence how we reinvest profits in a forward-thinking practice, that will remain independent. This is proving very attractive to new members of the team, which makes it a really exciting and rewarding time for us.”
Newly appointed vet, Emma Ball, has become one of the first new recruits to benefit from the EOT model after joining the group’s Sevenoaks practice. Emma said: “I initially did work experience at Pennard Vets eight years ago and immediately felt like part of the family. Everyone took the time to make sure I learnt as much as possible, so when I was offered this role, it was an easy decision for me.
“Coming back to the practice has been a fantastic experience and to benefit from the EOT is the icing on the cake. Although lots of people dream of owning their own practice, it’s a very difficult thing to achieve. However, now we’re all stakeholders in the business, it has made our team spirit even stronger and means everyone makes even more effort to make Pennard Vets successful and ensure clients always enjoy the very best level of care.”